BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia. (Q39624100)
Jump to navigation
Jump to search
scientific article published on 2 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia. |
scientific article published on 2 December 2010 |
Statements
BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia (English)
Grace Shimin Koh
Joshua Yew Lim
Shirley Kow Kham
Hany Ariffin
Allen Eng Yeoh
2 December 2010
321-9, 329.e1-3